356 related articles for article (PubMed ID: 19609471)
1. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
3. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
[TBL] [Abstract][Full Text] [Related]
6. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
8. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Schöfer H
Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
11. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Carrasco D; vander Straten M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
Gayed SL
Int J STD AIDS; 2002 May; 13(5):349-51. PubMed ID: 11972940
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
Gollnick H; Barasso R; Jappe U; Ward K; Eul A; Carey-Yard M; Milde K
Int J STD AIDS; 2001 Jan; 12(1):22-8. PubMed ID: 11177478
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
16. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
[TBL] [Abstract][Full Text] [Related]
17. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.
Rosenblatt A; de Campos Guidi HG
Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837
[TBL] [Abstract][Full Text] [Related]
18. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
19. Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: report of four cases and review of the literature.
Ciavattini A; Tsiroglou D; Vichi M; Di Giuseppe J; Cecchi S; Tranquilli AL
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):873-6. PubMed ID: 21815878
[TBL] [Abstract][Full Text] [Related]
20. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
